The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells

Journal of Neuroimmunology

Volumn 260, Issue 1-2, 2013, Pages 9-16

  Phan, Toan A ^a   Taylor, Andrew W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioparticles; Macrophages; Neuroimmunomodulation; Ocular Immune Privilege; Retina

Indexed keywords

ALPHA INTERMEDIN; CD206 ANTIGEN; FC RECEPTOR; MARCO PROTEIN; NEUROPEPTIDE Y; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; MACROPHAGE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOLYSOSOME; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ALPHA-MSH; ANIMALS; CELL LINE, TUMOR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; LEUKEMIA, MONOCYTIC, ACUTE; MACROPHAGES; MICE; NEUROIMMUNOMODULATION; NEUROPEPTIDE Y; PHAGOCYTOSIS; PHAGOSOMES; REACTIVE OXYGEN SPECIES; RETINA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84878623037     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.04.019     Document Type: Article

References (35)

1. Ahmed A.A., Wahbi A.H., Nordlin K. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol. Immunotoxicol. 2001, 23:397-409.
2. Bedoui S., von Horsten S., Gebhardt T. A role for neuropeptide Y (NPY) in phagocytosis: implications for innate and adaptive immunity. Peptides 2007, 28:373-376.
3. Brzoska T., Kalden D.H., Scholzen T., Luger T.A. Molecular basis of the alpha-MSH/IL-1 antagonism. Ann. N. Y. Acad. Sci. 1999, 885:230-238.
4. Catania A., Rajora N., Capsoni F., Minonzio F., Star R.A., Lipton J.M. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996, 17:675-679.
5. Connell P.P., O'Neill E.C., Fabinyi D., Islam F.M., Buttery R., McCombe M., Essex R.W., Roufail E., Clark B., Chiu D., Campbell W., Allen P. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye 2011, 25:66-72.
6. De la Fuente M., Medina S., Del Rio M., Ferrandez M.D., Hernanz A. Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci. 2000, 67:2125-2135.
7. De la Fuente M., Del Rio M., Medina S. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J. Neuroimmunol. 2001, 116:156-167.
8. Dimitrijevic M., Stanojevic S. The intriguing mission of neuropeptide Y in the immune system. Amino Acids 2011, (Epub ahead of print).
9. Dimitrijević M., Stanojević S., Vujić V., Beck-Sickinger A., von Hörsten S. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul. Pept. 2005, 124:163-172.
10. Getting S.J., Lam C.W., Chen A.S., Grieco P., Perretti M. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 2006, 20:2234-2241.
11. Haas A. The phagosome: compartment with a license to kill. Traffic 2007, 8:311-330.
12. Ichiyama T., Zhao H., Catania A., Furukawa S., Lipton J.M. Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation and IkappaBalpha degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 1999, 157:359-365.
13. Jankowski A., Grinstein S. Modulation of the cytosolic and phagosomal pH by the NADPH oxidase. Antioxid. Redox Signal. 2002, 4:61-68.
14. Kawanaka N., Taylor A.W. Localized retinal neuropeptide regulation of macrophage and microglial cell functionality. J. Neuroimmunol. 2010, 232:17-25.
15. Lam C.W., Perretti M., Getting S.J. Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 2006, 27:404-412.
16. Lau C.H., Taylor A.W. The immune privileged retina mediates an alternative activation of J774A.1 cells. Ocul. Immunol. Inflamm. 2009, 17:380-389.
17. Li D., Taylor A.W. Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J. Leukoc. Biol. 2008, 84:191-198.
18. Lipton J.M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 1997, 18:140-145.
19. Luger T.A., Kalden D., Scholzen T.E., Brzoska T. alpha-melanocyte-stimulating hormone as a mediator of tolerance induction. Pathobiology 1999, 67:318-321.
20. Manna S.K., Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 1998, 161:2873-2880.
21. Manna S.K., Sarkar A., Sreenivasan Y. Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur. J. Immunol. 2006, 36:754-769.
22. Medina S., Del Rio M., Hernanz A., De la Fuente M. The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication. Regul. Pept. 2000, 95:35-45.
23. Nave H., Bedoui S., Moenter F., Steffens J., Felies M., Gebhardt T., Straub R.H., Pabst R., Dimitrijevic M., Stanojevic S., von Horsten S. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol. 2004, 155:1-12.
24. Ness T., Pelz K., Hansen L.L. Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol. Scand. 2007, 85:852-856.
25. Niederkorn J.Y. The induction of anterior chamber-associated immune deviation. Chem. Immunol. Allergy 2007, 92:27-35.
26. Prod'homme T., Weber M.S., Steinman L., Zamvil S.S. A neuropeptide in immune-mediated inflammation, Y?. Trends Immunol. 2006, 27:164-167.
27. Puerto M., Guayerbas N., Alvarez P., De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J. Neuroimmunol. 2005, 165:33-40.
28. Sarkar A., Sreenivasan Y., Manna S.K. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett. 2003, 553:286-294.
29. Stanojevic S., Mitic K., Vujic V., Kovacevic-Jovanovic V., Dimitrijevic M. Exposure to acute physical and psychological stress alters the response of rat macrophages to corticosterone, neuropeptide Y and beta-endorphin. Stress 2007, 10:65-73.
30. Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., McDonnell P.J. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch. Ophthalmol. 2005, 123:613-620.
31. Taylor A.W. The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages. J. Neuroimmunol. 2005, 162:43-50.
32. Taylor A.W. Ocular immune privilege. Eye (Lond.) 2009, 23:1885-1889.
33. Yoon S.W., Goh S.H., Chun J.S., Cho E.W., Lee M.K., Kim K.L., Kim J.J., Kim C.J., Poo H. alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J. Biol. Chem. 2003, 278:32914-32920.
34. Zamiri P., Masli S., Streilein J.W., Taylor A.W. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3912-3918.
35. Zhou J.R., Xu Z., Jiang C.L. Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor. Neurosci. Bull. 2008, 24:155-159.